| ADR Ontology |
| ADR Term |
Bulbar palsy |
| ADR ID |
BADD_A07010 |
| ADR Hierarchy |
|
| Description |
A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. (Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115(Pt 6):1889-1900) [MeSH] |
| MedDRA Code |
10006542 |
| MeSH ID |
D010244
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Bulbar palsy | Bulbar paralysis | Paralysis bulbar | Bulbar Palsy, Progressive | Bulbar Palsies, Progressive | Palsies, Progressive Bulbar | Palsy, Progressive Bulbar | Progressive Bulbar Palsies | Progressive Bulbar Palsy | Bulbar Palsy | Bulbar Palsies | Palsies, Bulbar | Palsy, Bulbar | Paralysis, Bulbar | Bulbar Paralyses | Bulbar Paralysis | Childhood Progressive Bulbar Palsy | Bulbar Palsy, Progressive, Of Childhood | Progressive Bulbar Palsy of Childhood | Fazio-Londe Syndrome | Fazio Londe Syndrome | Fazio-Londe Disease | Fazio Londe Disease |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01633 | Oxaliplatin | 0.000224% | | | BADD_D02464 | Fingolimod | 0.000241% | |
| The 1th Page 1
Total 1 Pages
|
|
